Stock Earnings

Question 1

What are Infinity Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Infinity Pharmaceuticals Inc has a total asset of $42, Net loss of $-44

Question 2

What are the key financial ratios for INFIQ?

Accepted Answer

Infinity Pharmaceuticals Inc's Current ratio is 0.68, has a Net margin is -2,200, sales per share of $0.02.

Question 3

How is Infinity Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Infinity Pharmaceuticals Inc data is not available.

Question 4

Is Infinity Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Infinity Pharmaceuticals Inc has a net loss of $-44

Question 5

Does Infinity Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Infinity Pharmaceuticals Inc has liability of 61

Question 6

How many outstanding shares for Infinity Pharmaceuticals Inc?

Accepted Answer

Infinity Pharmaceuticals Inc has a total outstanding shares of 89.4

Breakdown	TTM	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	2	2	1	1	3	22
Revenue Growth (YoY)	0%	100%	0%	-67%	-86%	267%
Cost of Revenue	1	1	1	1	7	0
Gross Profit	1	1	0	0	-4	22
Selling, General & Admin	16	13	14	12	14	14
Research & Development	27	32	31	26	27	19
Operating Expenses	43	45	45	39	41	34
Other Non Operating Income (Expenses)	--	--	--	--	--	0
Pretax Income	-40	-44	-45	-40	-47	-11
Income Tax Expense	--	--	--	0	0	0
Net Income	-40	-44	-45	-40	-47	-11
Net Income Growth	-13%	-2%	13%	-15%	327%	-73%
Shares Outstanding (Diluted)	89.9	89.2	85.6	59.9	57	55.4
Shares Change (YoY)	1%	4%	43%	5%	3%	9%
EPS (Diluted)	-0.45	-0.5	-0.53	-0.68	-0.83	-0.2
EPS Growth	-13%	-6%	-22%	-18%	315%	-76%
Free Cash Flow	-38	-42	-40	-35	-43	-4
Free Cash Flow Per Share	-0.42	-0.47	-0.46	-0.58	-0.75	-0.07
Gross Margin	50%	50%	0%	0%	-133.33%	100%
Operating Margin	-2,100%	-2,200%	-4,500%	-3,800%	-1,500%	-50%
Profit Margin	-2,000%	-2,200%	-4,500%	-4,000%	-1,566.66%	-50%
Free Cash Flow Margin	-1,900%	-2,100%	-4,000%	-3,500%	-1,433.33%	-18.18%
EBITDA	-42	-44	-45	-38	-45	-11
EBITDA Margin	-2,100%	-2,200%	-4,500%	-3,800%	-1,500%	-50%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-42	-44	-45	-38	-45	-11
EBIT Margin	-2,100%	-2,200%	-4,500%	-3,800%	-1,500%	-50%
Effective Tax Rate	--	--	--	0%	0%	0%

Infinity Pharmaceuticals Inc (INFIQ) Price